Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Prostatic Neoplasms × Granulocyte Colony-Stimulating Factor × Clear all

Phase

Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 4 Lymphoma 3 Neoplasm, Residual 2 Lymphoma, Non-Hodgkin 2 Breast Neoplasms 2 Retinoblastoma 1 Recurrence 1 Prostatic Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mediastinal Neoplasms 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia 1 Hepatoblastoma 1 Chemotherapy-Induced Febrile Neutropenia 1 Burkitt Lymphoma 1

Interventions

Zoledronic Acid 14 Leuprolide 9 bicalutamide 6 Triptorelin Pamoate 6 Goserelin 6 luprolide acetate gel depot 5 enzalutamide 5 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5 Dutasteride 5 darolutamide 3 Sodium Chloride 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Flutamide 3 Androgen Antagonists 3 Abiraterone Acetate 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 fluciclovine F-18 2 cabazitaxel 2 Propofol 2 Prednisolone 2 Lidocaine 2 Gonadotropin-Releasing Hormone 2 Finasteride 2 Dexamethasone 2 Desflurane 2 Ciprofloxacin 2 testosterone 17 beta-cypionate 1 semaglutide 1 polyethylene glycol 3350 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01649635 2016-07-06

PROSPECTA

Sanofi

Phase 4 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡